NextPlat Corp: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über NextPlat Corp Unternehmen

NextPlat Corp is a consumer products and services company providing healthcare and technology solutions through e-Commerce and retail channels worldwide. It is operating in the e-Commerce and Healthcare sectors. Through acquisitions, joint ventures, and collaborations, the Company seeks to assist businesses in selling their goods online, domestically, and internationally. The Company operates an e-Commerce communications division offering voice, data, tracking, and Internet of Things (IoT) products and services worldwide as well as pharmacy and healthcare data management services in the United States through its subsidiary, Progressive Care Inc. Additionally, the Company provides a comprehensive array of Satellite Industry communication services and related equipment sales. It also utilizes an artificial-intelligence (AI)-powered digital advertising platform service enabling it to reach consumers across social media channels.

NextPlat Corp Informationen



BörsenkürzelNXPL

Name des UnternehmensNextPlat Corp

IPO-datumMar 15, 1999

CEOPhipps (David)

Anzahl der mitarbeiter162

WertpapierartOrdinary Share

GeschäftsjahresendeMar 15

Addresse400 Ansin Blvd

StadtHALLANDALE BEACH

BörseNASDAQ OMX - NASDAQ BASIC

LandUnited States of America

Postleitzahl33009

Telefon13055605381

Websitehttps://ir.nextplat.com/

BörsenkürzelNXPL

IPO-datumMar 15, 1999

CEOPhipps (David)

Führungskräfte von NextPlat Corp



Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Rodney Barreto

Non-Executive Independent Chairman of the Board

228.51K

+1.06%

Mr. David Phipps

President, Chief Executive Officer, Director, Chief Executive Officer - Global Operations

67.18K

-7.44%

Ms. Elizabeth Alcaine

Independent Director

60.57K

--

Mr. Louis Cusimano

Independent Director

35.43K

-56.44%

Mr. Anthony Armas

Independent Director

10.12K

+40.12%

Mr. Hector Delgado

Independent Director

5.46K

+54.95%

Mr. Douglas S. Ellenoff

Vice Chairman of the Board, Chief Business Development Strategist

--

Mr. Robert Bedwell

Chief Compliance Officer

--

Mr. Michael Glickman

Investor Relations

--

Ms. Amanda L. Ferrio

Chief Financial Officer

--

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Rodney Barreto

Non-Executive Independent Chairman of the Board

228.51K

+1.06%

Mr. David Phipps

President, Chief Executive Officer, Director, Chief Executive Officer - Global Operations

67.18K

-7.44%

Ms. Elizabeth Alcaine

Independent Director

60.57K

--

Mr. Louis Cusimano

Independent Director

35.43K

-56.44%

Mr. Anthony Armas

Independent Director

10.12K

+40.12%

Mr. Hector Delgado

Independent Director

5.46K

+54.95%

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Apr 6

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Pharmacy Prescription And Other Revenue Net Of Pbm Fees

35.70M

65.73%

e-Commerce revenue

14.61M

26.89%

Pharmacy 340B contract revenue

4.01M

27.45%

Nach RegionUSD

Name

Umsatz

Anteil

Europe

7.45M

51.01%

North America

4.68M

32.06%

Asia & Pacific

1.97M

13.47%

Africa

462.00K

3.16%

South America

44.00K

0.30%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Pharmacy Prescription And Other Revenue Net Of Pbm Fees

35.70M

65.73%

e-Commerce revenue

14.61M

26.89%

Pharmacy 340B contract revenue

4.01M

27.45%

Aktionärsstatistik

Aktualisiert: Thu, May 14

Aktionäre

Aktionärstypen

Aktionäre

Anteil

Fernandez (Lauren Sturges)

14.74%

Frost Gamma Investments Trust

12.66%

Barreto (Rodney)

8.44%

Keyser (Robert)

3.53%

Phipps (David)

2.48%

Andere

58.16%

Aktionäre

Anteil

Fernandez (Lauren Sturges)

14.74%

Frost Gamma Investments Trust

12.66%

Barreto (Rodney)

8.44%

Keyser (Robert)

3.53%

Phipps (David)

2.48%

Andere

58.16%

Aktionärstypen

Aktionäre

Anteil

Individual Investor

31.24%

Corporation

12.66%

Investment Advisor

4.42%

Investment Advisor/Hedge Fund

1.10%

Hedge Fund

0.42%

Venture Capital

0.09%

Research Firm

0.07%

Andere

50.01%

Institutionelle Beteiligung



Aktualisiert: Wed, Apr 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2026Q1

39

165.11K

6.10%

-46.74K

2025Q4

35

1.37M

5.23%

-683.27K

2025Q3

34

1.91M

7.36%

+624.43K

2025Q2

43

13.26M

51.07%

+1.66M

2025Q1

43

11.85M

60.63%

+595.42K

2024Q4

41

12.22M

47.07%

+1.42M

2024Q3

33

11.44M

52.41%

+839.72K

2024Q2

34

11.11M

57.81%

+518.97K

2024Q1

35

11.08M

58.38%

+876.45K

2023Q4

35

10.68M

71.96%

+7.69M

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

Fernandez (Lauren Sturges)

3.99M

14.77%

+3.97M

+15867.40%

Mar 02, 2026

Frost Gamma Investments Trust

3.43M

12.69%

--

Mar 02, 2026

Barreto (Rodney)

2.26M

8.37%

--

Mar 02, 2026

Keyser (Robert)

955.57K

3.54%

-23.93K

-2.44%

Mar 02, 2026

Phipps (David)

671.79K

2.49%

-50.00K

-6.93%

Mar 02, 2026

EverSource Wealth Advisors, LLC

580.69K

2.15%

--

Dec 31, 2025

Geode Capital Management, L.L.C.

224.46K

0.83%

--

Dec 31, 2025

Ellenoff (Douglas S.)

166.18K

0.61%

--

Mar 02, 2026

Hough (Jervis Bennett)

127.67K

0.47%

+127.67K

--

Oct 01, 2024

Verbundene ETFs



Aktualisiert: Tue, Dec 2

Name

Anteil

iShares Micro-Cap ETF

0%

Fidelity Nasdaq Composite Index ETF

0%

Dimensional US Core Equity 1 ETF

0%

iShares Micro-Cap ETF

Anteil0%

Fidelity Nasdaq Composite Index ETF

Anteil0%

Dimensional US Core Equity 1 ETF

Anteil0%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split



Datum

Ex-Dividendentag

Art

Verhältnis

Mar 27, 2026

Merger

10→1

Datum

Ex-Dividendentag

Art

Verhältnis

Mar 27, 2026

Merger

10→1